{
  "issued_date": "2013-06-27", 
  "original_url": "http://www.mhra.gov.uk/Publications/Safetywarnings/DrugAlerts/CON287025", 
  "doc_details": {
    "Type": "Drug Alert", 
    "Series No": "EL (13)A/18", 
    "Audience": "Healthcare professionals", 
    "Published": "27 June 2013", 
    "Format": "Electronic only", 
    "Size": "A4", 
    "Pages": "2", 
    "Price": "", 
    "ISBN/ISSN": "", 
    "Author": "", 
    "Copyright": "Crown"
  }, 
  "_assets": [
    {
      "content_type": "application/pdf", 
      "title": " Class 2 Drug Alert (Action Within 48 Hours): Hydroxyethyl Starch (HES) products - B Braun Melsungen AG and Fresenius Kabi Limited (EL (13)A/18) (198Kb)", 
      "assetid": 0, 
      "original_url": "http://www.mhra.gov.uk/home/groups/is-md/documents/drugalert/con287026.pdf", 
      "filename": "downloads/ed9e47d4bbfa6081492363b488253c71abba6c36/con287026.pdf", 
      "original_filename": "con287026.pdf"
    }
  ], 
  "body": "## DRUG ALERT\n\nCLASS 2 MEDICINES RECALL\n\nAction Within 48 Hours\n\n  \n\n\nPharmacy, Clinic and Wholesaler Level Recall  \n  \n27 June 2013  |   |  EL (13)A/18  |   |  Our ref:\u00a0 MDR 22-06/13   | \n\n* * *\n\nDear Healthcare Professional,\n\nB Braun Melsungen AG and Fresenius Kabi Limited\n\nHydroxyethyl Starch (HES) products\n\nVarious PL numbers (see below)\n\n### B Braun Melsungen AG  \n  \nHydroxyethyl Starch (HES) products |   \nTetraspan 10% solution for infusion (500ml)  |   |  PL 03551/0107  |   \nTetraspan 6% solution for infusion (500ml)  |   |  PL 03551/0106  |   \nVenofundin 60mg/ml solution for infusion (500ml)  |   |  PL 03551/0097  | \n\n### Fresenius Kabi Limited  \n  \nHydroxyethyl Starch (HES) products\u00a0 |   \nVoluven 10% solution for infusion (500ml)  |   |  PL 08828/0207  |   \nVoluven 6% solution for infusion (500ml)  |   |  PL 08828/0145  |   \nVolulyte 6% solution for infusion (500ml)  |   |  PL 08828/0174  | \n\n  \nAll unexpired stock of these products is being recalled to pharmacy, clinic and wholesaler level irrespective of batch number and expiry date.\n\nThese products are being withdrawn after results from large randomised clinical trials have reported an increased risk of renal dysfunction and mortality in critically ill or septic patients who received hydroxyethyl starch (HES) compared with crystalloids (simple salt solutions). The UK Commission on Human Medicines (CHM) has concluded that the benefits no longer outweigh the risks.\n\nNo further hydroxyethyl starch (HES) products should be dispensed. An alternative resuscitation fluid should be selected according to clinical guidelines.\n\nRemaining stocks of the affected batches should be quarantined and returned to the original supplier for credit. \u00a0For enquiries relating to stock returns please contact:\n\nB Braun Medical Limited (UK) on 01142 259 155.  \nFresenius Kabi Limited Customer Services on 01928 533 697.\n\nFor medical information enquiries please contact:\n\nB Braun Medical Limited (UK) Medical Information on 01142 259 159.\n\nFresenius Kabi Limited Medical Information on 01928 533 612 or email [pharmacovigilance.GB@fresenius-kabi.com](mailto:pharmacovigilance.GB@fresenius-kabi.com).\n\nRecipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. Local area teams are asked to forward this to relevant clinics, general practitioners and community pharmacists for information.\n\nYours faithfully\n\nAdam Burgess  \nDefective Medicines Report Centre  \n151 Buckingham Palace Road  \nLondon  \nSW1W 9SZ  \nTelephone +44 (0)20 3080 6574\n\nMHRA Distribution (further recipients by cascade):  . \n\n### Download documents:  \n  \n  * [ASSET_TAG](#ASSET0)\n", 
  "raw_html": "<div class=\"inner\">          \r\n\t\t\t\t<a name=\"main\"></a>\r\n\t\t\t\t\r\n\t\t\t\t<div class=\"title\">\r\n\t\t\t\t\t<h2>DRUG ALERT</h2>\r\n\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element14)-->\r\n\t\t\t\t\t<p>CLASS 2 MEDICINES RECALL</p>\r\n\t\t\t\t\t<!--SS_END_ELEMENT(region1_element14)-->\r\n\t\t\t\t</div>\r\n\t\t\t\t\r\n\t\t\t\t<div class=\"drugalertdetails\">\r\n\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element15)-->\r\n\t\t\t\t\t<p>Action Within 48 Hours</p>\r\n\t\t\t\t\t<!--SS_END_ELEMENT(region1_element15)-->\r\n\t\t\t\t\t<br>\r\n\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element16)-->\r\n\t\t\t\t\t<p>Pharmacy, Clinic and Wholesaler Level Recall</p>\r\n\t\t\t\t\t<!--SS_END_ELEMENT(region1_element16)-->\r\n\t\t\t\r\n\t\t\t\t\t<table id=\"dateref\">\r\n\t\t\t\t\t\t<tr>\r\n\t\t\t\t\t\t\t<td align=\"left\">\r\n\t\t\t\t\t\t\t\r\n\r\n\t\t\t\t\t\t\t27 June 2013\r\n\t\t\t\t\t\t\t</td>\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t<td>\r\n\t\t\t\t\t\t\tEL (13)A/18\r\n\t\t\t\t\t\t\t</td>\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t<td align=\"right\">\r\n\t\t\t\t\t\t\t\tOur ref:&#160;\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element17)-->\r\n\t\t\t\t\t\t\t\t MDR 22-06/13 \r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element17)-->\r\n\t\t\t\t\t\t\t</td>\r\n\t\t\t\t\t\t</tr>\r\n\t\t\t\t\t</table>\r\n\t\t\t\t</div>\r\n\t\t\t\t<hr>\t\t\t\t\r\n          \t\t<!--SS_BEGIN_ELEMENT(region1_element12)-->\r\n          \t\t<!--SS_END_ELEMENT(region1_element12)--> \r\n          \t\t\r\n          \t\t \r\n          \t\t\r\n          \t\t<p>Dear Healthcare Professional,</p>\r\n\r\n\t\t\t\t<div class=\"druginfo\">\r\n\t\t\t\t\t<div class=\"left\">\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t<p>\r\n\t\t\t\t\t\t\t<span>B Braun Melsungen AG and Fresenius Kabi Limited</span>\r\n\t\t\t\t\t\t</p>\r\n\t\t\t\t\t\t\t\t\t\t\r\n          \t\t          \t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t<p>\r\n\t\t\t\t\t\t\t<span>Hydroxyethyl Starch (HES) products</span>\r\n\t\t\t\t\t\t</p>\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t</div>\r\n\t\t\t\t\t\r\n\t\t\t\t\t<div class=\"right\">\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t<span>Various PL numbers (see below)</span>\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t</div>\t\r\n\t\t\t\t</div>\t\t\t\t\r\n          \t\t\r\n\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment8,navigation_controls)-->\r\n\t\t\t\t<!-- only show the publication navigation controls if there is more than one page to the publication -->\r\n\t\t\t\r\n\t\t\t\t<!-- SS_END_SNIPPET(fragment8,navigation_controls)-->\r\n \t\t\r\n\t\t\t\t<!-- SS_BEGIN_SNIPPET(region1_element2,paged_publication)-->\r\n        \t\t<!-- <br>SS_DATAFILE: CON287025 -->\r\n\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<p></p><h3>B Braun Melsungen AG</h3>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\">\n<tr>\n<td valign=\"top\" colspan=\"2\" width=\"683.0\"><span>Hydroxyethyl Starch (HES) products</span></td>\n</tr>\n\n<tr>\n<td width=\"426\" valign=\"top\">\n Tetraspan 10% solution for infusion (500ml) \n</td>\n<td valign=\"top\" style=\" width: 257px;\">\n PL 03551/0107 \n</td>\n</tr>\n\n<tr>\n<td width=\"426\" valign=\"top\">\n Tetraspan 6% solution for infusion (500ml) \n</td>\n<td valign=\"top\" style=\" width: 257px;\">\n PL 03551/0106 \n</td>\n</tr>\n\n<tr>\n<td width=\"426\" valign=\"top\">\n Venofundin 60mg/ml solution for infusion (500ml) \n</td>\n<td valign=\"top\" style=\" width: 257px;\">\n PL 03551/0097 \n</td>\n</tr>\n</table>\n\n<h3>Fresenius Kabi Limited</h3>\n\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\">\n<tr>\n<td valign=\"top\" colspan=\"2\" width=\"687.0\"><span>Hydroxyethyl Starch (HES) products&#160;</span></td>\n</tr>\n\n<tr>\n<td width=\"426\" valign=\"top\">\n Voluven 10% solution for infusion (500ml) \n</td>\n<td width=\"261\" valign=\"top\" style=\" text-align: right;\">\n PL 08828/0207 \n</td>\n</tr>\n\n<tr>\n<td width=\"426\" valign=\"top\">\n Voluven 6% solution for infusion (500ml) \n</td>\n<td width=\"261\" valign=\"top\" style=\" text-align: right;\">\n PL 08828/0145 \n</td>\n</tr>\n\n<tr>\n<td width=\"426\" valign=\"top\">\n Volulyte 6% solution for infusion (500ml) \n</td>\n<td width=\"261\" valign=\"top\" style=\" text-align: right;\">\n PL 08828/0174 \n</td>\n</tr>\n</table>\n\n<p><br>\nAll unexpired stock of these products is being recalled to pharmacy, clinic and wholesaler level irrespective of batch number and expiry date.</p>\n\n<p>These products are being withdrawn after results from large randomised clinical trials have reported an increased risk of renal dysfunction and mortality in critically ill or septic patients who received hydroxyethyl starch (HES) compared with crystalloids (simple salt solutions). The UK Commission on Human Medicines (CHM) has concluded that the benefits no longer outweigh the risks.</p>\n\n<p>No further hydroxyethyl starch (HES) products should be dispensed. An alternative resuscitation fluid should be selected according to clinical guidelines.</p>\n\n<p>Remaining stocks of the affected batches should be quarantined and returned to the original supplier for credit. &#160;For enquiries relating to stock returns please contact:</p>\n\n<p>B Braun Medical Limited (UK) on 01142 259 155.<br>\nFresenius Kabi Limited Customer Services on 01928 533 697.</p>\n\n<p>For medical information enquiries please contact:</p>\n\n<p>B Braun Medical Limited (UK) Medical Information on 01142 259 159.</p>\n\n<p>Fresenius Kabi Limited Medical Information on 01928 533 612 or email <a href=\"mailto:pharmacovigilance.GB@fresenius-kabi.com\">pharmacovigilance.GB@fresenius-kabi.com</a>.</p>\n\n<p>Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. Local area teams are asked to forward this to relevant clinics, general practitioners and community pharmacists for information.</p>\n\n<p>Yours faithfully</p>\n\n<p><span>Adam Burgess<br>\nDefective Medicines Report Centre<br>\n151 Buckingham Palace Road<br>\nLondon<br>\nSW1W 9SZ<br>\nTelephone +44 (0)20 3080 6574</span></p>\r\n\r\n\t\t\t\r\n        \t\t<!-- SS_END_SNIPPET(region1_element2,paged_publication)-->\r\n        \t\t\r\n        \t\tMHRA Distribution (further recipients by cascade):\r\n        \t\t\r\n        \t\t <!--SS_BEGIN_ELEMENT(region1_element18)-->\r\n        \t\t.\r\n        \t\t<!--SS_END_ELEMENT(region1_element18)-->\r\n \t\t\r\n\t\t\t\t<!-- SS_BEGIN_SNIPPET(region1_element3,static_pdf_list)-->\r\n        \t\t<!-- the xmlListTag variable is used by the searchDocsByContentIdList include to map the name of the XML node which contains the content id -->\r\n<!--perform the search -->\r\n\t\r\n\t<!-- <br>root: Content/AssociatedContent -->\r\n\t<!-- <br>ssFragmentInstanceId: region1_element3\t -->\r\n\t<!-- <br>SS_DATAFILE: CON287025 -->\r\n\t<!-- <br>xmlListTag: ContentId\t -->\r\n\t<!-- <br>XPATH: CON287025/Content/AssociatedContent/ContentId\t -->\r\n\r\n\t<!-- xmlListTag variable should be the name of the xml node which contains a contentid.  there should be a lis of these in the XML -->\r\n\t<!-- <br>strNumRecords: 1 -->\r\n\t<!-- <br>nNumRecords: 1 -->\r\n\r\n\t\t\t<!-- using the content ID above, get the docment from conetent server-->\r\n\r\n\t\t\t\r\n\r\n\t\t<!--  dDocName <matches>`CON287026` -->\r\n\t\t\r\n<div id=\"downloadArea\">\r\n\t<h3>Download documents:</h3>\r\n\t<ul>\r\n\t\t<!-- the SearchResults will have been initialised by the call to searchDocsByContentIdList above-->\r\n\t\t\t\r\n\t\t\t\t<li>\r\n\r\n\t\t\t\t\t\t<a href=\"#ASSET0\">ASSET_TAG</a>\r\n\t\t\t\t</li>\r\n\t</ul>\r\n\t<div class=\"clearing\"><!--  --></div>\r\n\t<!--<p><a class=\"doubleArrow\" target=\"new\" href=\"http://www.adobe.com/products/acrobat/readstep2.html\">Download Acrobat Reader for free</a></p>\r\n\t<p><a class=\"doubleArrow\" target=\"new\" href=\"http://www.adobe.com/products/acrobat/access_onlinetools.html\">Adobe text conversion tools</a></p>-->\r\n</div>\r\n\t\t\t\r\n        \t\t<!-- SS_END_SNIPPET(region1_element3,static_pdf_list)-->\r\n \t\t\r\n\t\t\t\t<!-- SS_BEGIN_CLOSEREGIONMARKER(region1)-->\r\n        \t\t\r\n        \t\t<!-- SS_END_CLOSEREGIONMARKER(region1)-->\r\n\t\t\t</div>\r\n\t\t", 
  "title": "Class 2 Drug Alert (Action Within 48 Hours): Hydroxyethyl Starch (HES) products - B Braun Melsungen AG and Fresenius Kabi Limited (EL (13)A/18)", 
  "alert_type": [
    "drugs"
  ], 
  "medical_specialism": []
}